Metabolomic signatures associated with disease severity in multiple sclerosis
Pablo Villoslada(Hospital Del Mar), Azucena Castro(OWL (Spain)), Roberto Álvarez‐Lafuente(Hospital Clínico San Carlos), Xavier Montalbán(Universitat de Vic - Universitat Central de Catalunya), Óscar Fernández(Universidad de Málaga), Irati Zubizarreta(University of California, San Francisco), Ekaterina Kotelnikova(University of California, San Francisco), Albert Saiz(Neurology, Inc), Cristina Alonso(Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas), Luisa María Villar(Evidence (Italy)), Manuel Comabella(Universitat Autònoma de Barcelona), Rafael Arroyo, Ion Agirrezabal(University of California, San Francisco), José C. Álvarez‐Cermeño(Hospital Universitario Ramón y Cajal), Irene Pulido‐Valdeolivas(University of California, San Francisco)
Cited by 111
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
A clinical approach to diagnosis of autoimmune encephalitis
|The Lancet Neurology|2016|4.4k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k